Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size, Status and Forecast 2024-2031

Report ID: 922418 | Published Date: Jan 2026 | No. of Page: 95 | Base Year: 2025 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Nusinersen
        1.2.3 Onasemnogen Abeparvovec
    1.3 Market by Application
        1.3.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Type 1 SMA
        1.3.3 Type 2 SMA
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Perspective (2016-2027)
    2.2 Spinal Muscular Atrophy (SMA) Therapeutic Growth Trends by Regions
        2.2.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Spinal Muscular Atrophy (SMA) Therapeutic Historic Market Share by Regions (2016-2021)
        2.2.3 Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Regions (2022-2027)
    2.3 Spinal Muscular Atrophy (SMA) Therapeutic Industry Dynamic
        2.3.1 Spinal Muscular Atrophy (SMA) Therapeutic Market Trends
        2.3.2 Spinal Muscular Atrophy (SMA) Therapeutic Market Drivers
        2.3.3 Spinal Muscular Atrophy (SMA) Therapeutic Market Challenges
        2.3.4 Spinal Muscular Atrophy (SMA) Therapeutic Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Spinal Muscular Atrophy (SMA) Therapeutic Players by Revenue
        3.1.1 Global Top Spinal Muscular Atrophy (SMA) Therapeutic Players by Revenue (2016-2021)
        3.1.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Players (2016-2021)
    3.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Spinal Muscular Atrophy (SMA) Therapeutic Revenue
    3.4 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Concentration Ratio
        3.4.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy (SMA) Therapeutic Revenue in 2020
    3.5 Spinal Muscular Atrophy (SMA) Therapeutic Key Players Head office and Area Served
    3.6 Key Players Spinal Muscular Atrophy (SMA) Therapeutic Product Solution and Service
    3.7 Date of Enter into Spinal Muscular Atrophy (SMA) Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Spinal Muscular Atrophy (SMA) Therapeutic Breakdown Data by Type
    4.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Historic Market Size by Type (2016-2021)
    4.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Type (2022-2027)

5 Spinal Muscular Atrophy (SMA) Therapeutic Breakdown Data by Application
    5.1 Global Spinal Muscular Atrophy (SMA) Therapeutic Historic Market Size by Application (2016-2021)
    5.2 Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
    6.2 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
        6.2.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
        6.2.2 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
        6.2.3 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
    6.3 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
        6.3.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
        6.3.2 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
        6.3.3 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
    6.4 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country
        6.4.1 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021)
        6.4.2 North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
    7.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
        7.2.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
        7.2.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
        7.2.3 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
    7.3 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
        7.3.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
        7.3.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
        7.3.3 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
    7.4 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country
        7.4.1 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021)
        7.4.2 Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
    8.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
        8.2.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
    8.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
        8.3.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
    8.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region
        8.4.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
    9.2 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
        9.2.1 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
        9.2.2 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
        9.2.3 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
    9.3 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
        9.3.1 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
        9.3.2 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
        9.3.3 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
    9.4 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country
        9.4.1 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021)
        9.4.2 Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size (2016-2027)
    10.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type
        10.2.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2027)
    10.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application
        10.3.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2027)
    10.4 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country
        10.4.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Biogen
        11.1.1 Biogen Company Details
        11.1.2 Biogen Business Overview
        11.1.3 Biogen Spinal Muscular Atrophy (SMA) Therapeutic Introduction
        11.1.4 Biogen Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
        11.1.5 Biogen Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Spinal Muscular Atrophy (SMA) Therapeutic Introduction
        11.2.4 Novartis Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Roche
        11.3.1 Roche Company Details
        11.3.2 Roche Business Overview
        11.3.3 Roche Spinal Muscular Atrophy (SMA) Therapeutic Introduction
        11.3.4 Roche Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
        11.3.5 Roche Recent Development
    11.4 Astellas Pharma
        11.4.1 Astellas Pharma Company Details
        11.4.2 Astellas Pharma Business Overview
        11.4.3 Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Introduction
        11.4.4 Astellas Pharma Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
        11.4.5 Astellas Pharma Recent Development
    11.5 Genzyme Corporation
        11.5.1 Genzyme Corporation Company Details
        11.5.2 Genzyme Corporation Business Overview
        11.5.3 Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Introduction
        11.5.4 Genzyme Corporation Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
        11.5.5 Genzyme Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Nusinersen
    Table 3. Key Players of Onasemnogen Abeparvovec
    Table 4. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Regions (2016-2021)
    Table 8. Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Regions (2022-2027)
    Table 10. Spinal Muscular Atrophy (SMA) Therapeutic Market Trends
    Table 11. Spinal Muscular Atrophy (SMA) Therapeutic Market Drivers
    Table 12. Spinal Muscular Atrophy (SMA) Therapeutic Market Challenges
    Table 13. Spinal Muscular Atrophy (SMA) Therapeutic Market Restraints
    Table 14. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Players (2016-2021)
    Table 16. Global Top Spinal Muscular Atrophy (SMA) Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Therapeutic as of 2020)
    Table 17. Ranking of Global Top Spinal Muscular Atrophy (SMA) Therapeutic Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Spinal Muscular Atrophy (SMA) Therapeutic Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Spinal Muscular Atrophy (SMA) Therapeutic Product Solution and Service
    Table 21. Date of Enter into Spinal Muscular Atrophy (SMA) Therapeutic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Type (2016-2021)
    Table 25. Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Application (2016-2021)
    Table 29. Global Spinal Muscular Atrophy (SMA) Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Biogen Company Details
    Table 62. Biogen Business Overview
    Table 63. Biogen Spinal Muscular Atrophy (SMA) Therapeutic Product
    Table 64. Biogen Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
    Table 65. Biogen Recent Development
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Spinal Muscular Atrophy (SMA) Therapeutic Product
    Table 69. Novartis Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Roche Company Details
    Table 72. Roche Business Overview
    Table 73. Roche Spinal Muscular Atrophy (SMA) Therapeutic Product
    Table 74. Roche Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
    Table 75. Roche Recent Development
    Table 76. Astellas Pharma Company Details
    Table 77. Astellas Pharma Business Overview
    Table 78. Astellas Pharma Spinal Muscular Atrophy (SMA) Therapeutic Product
    Table 79. Astellas Pharma Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
    Table 80. Astellas Pharma Recent Development
    Table 81. Genzyme Corporation Company Details
    Table 82. Genzyme Corporation Business Overview
    Table 83. Genzyme Corporation Spinal Muscular Atrophy (SMA) Therapeutic Product
    Table 84. Genzyme Corporation Revenue in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021) & (US$ Million)
    Table 85. Genzyme Corporation Recent Development
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type: 2020 VS 2027
    Figure 2. Nusinersen Features
    Figure 3. Onasemnogen Abeparvovec Features
    Figure 4. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application: 2020 VS 2027
    Figure 5. Type 1 SMA Case Studies
    Figure 6. Type 2 SMA Case Studies
    Figure 7. Other Case Studies
    Figure 8. Spinal Muscular Atrophy (SMA) Therapeutic Report Years Considered
    Figure 9. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Regions: 2020 VS 2027
    Figure 12. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Regions (2022-2027)
    Figure 13. Global Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Players in 2020
    Figure 14. Global Top Spinal Muscular Atrophy (SMA) Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Therapeutic as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Therapeutic Revenue in 2020
    Figure 16. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Type (2016-2021)
    Figure 17. Global Spinal Muscular Atrophy (SMA) Therapeutic Revenue Market Share by Type (2022-2027)
    Figure 18. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
    Figure 20. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
    Figure 21. North America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Country (2016-2027)
    Figure 22. United States Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
    Figure 26. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
    Figure 27. Europe Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Country (2016-2027)
    Figure 28. Germany Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Region (2016-2027)
    Figure 38. China Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
    Figure 46. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
    Figure 47. Latin America Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Country (2016-2027)
    Figure 48. Mexico Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Spinal Muscular Atrophy (SMA) Therapeutic Market Share by Country (2016-2027)
    Figure 54. Turkey Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Spinal Muscular Atrophy (SMA) Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Biogen Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
    Figure 58. Novartis Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
    Figure 59. Roche Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
    Figure 60. Astellas Pharma Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
    Figure 61. Genzyme Corporation Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Therapeutic Business (2016-2021)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biogen
Novartis
Roche
Astellas Pharma
Genzyme Corporation
Frequently Asked Questions
Spinal Muscular Atrophy (SMA) Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Spinal Muscular Atrophy (SMA) Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Spinal Muscular Atrophy (SMA) Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports